NCT00326352

Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (planned)
• Sponsor: University of Edinburgh · Academic / Other
• Sex: All
• Age: 16 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

For reduction of dislocated shoulder, sedation with propofol and remifentanil should give satisfactory operating conditions and pain relief, and significantly reduce the time to full recovery, compared with morphine and midazolam

Detailed description

Propofol is a recognised agent for sedation and remifentanil is a short acting opioid analgesic. We intend to provide sedation with propofol, 0.5 mg/Kg, and analgesia with remifentanil 0.5 microgram/Kg for reduction of dislocated shoulders. This will be a randomised sex-stratified comparison with current therapy which is midazolam incrementally up to a maximum of 0.15 mg/Kg, and morphine incrementally up to 0.15 mg/Kg. The primary outcome measure is time to full recovery. Secondary aspects are pain or discomfort during the procedure and operating conditions.

Conditions

• Shoulder Dislocation

Interventions

Type	Name	Description
DRUG	Sedation with propofol and remifentanil

Timeline

• Start date: 2003-07-01
• Completion: 2005-06-01
• First posted: 2006-05-16
• Last updated: 2006-05-16

Locations

1 site across 1 country: United Kingdom